StockDriftsStockDriftsTop 30 Squadron Capital Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | 23.6% | 8.47M | $59.0M | +26.49%(+1.77M) | $3.94(+59.46%) | 2026-03-31 | |
| COGT | COGENT BIOSCIENCES INC | 12.13% | 787.5K | $30.3M | +0.96%(+7.49K) | $25.05(+54.42%) | 2026-03-31 | |
| KALV | KALVISTA PHARMACEUTICALS INC | 7.93% | 985.1K | $19.8M | +40.73%(+285.10K) | $15.32(+74.53%) | 2026-03-31 | |
| KOD | KODIAK SCIENCES INC | 5.8% | 380.0K | $14.5M | +30.27%(+88.29K) | $24.69(+56.08%) | 2026-03-31 | |
| ABVX | ABIVAX SA | 5.79% | 130.0K | $14.5M | -10.34%(-15.00K) | $109.88(+31.65%) | 2026-03-31 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 4.41% | 350.0K | $11.0M | +0.00%(+0) | $20.52(+92.81%) | 2026-03-31 | |
| NKTR | NEKTAR THERAPEUTICS | 3.6% | 125.0K | $9.0M | new | $57.11(+24.38%) | 2026-03-31 | |
| ANL | ADLAI NORTYE LTD | 3.5% | 1.27M | $8.8M | new | $4.17(+127.58%) | 2026-03-31 | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 3.4% | 3.63M | $8.5M | new | $1.84(+141.73%) | 2026-03-31 | |
| MAZE | MAZE THERAPEUTICS INC | 3.08% | 257.5K | $7.7M | -47.45%(-232.50K) | $33.68(-7.19%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | — | — |
| Top 20 Holdings Unweighted | — | — |
Sign up free to track Squadron Capital Management LLC, compare funds side by side, and get alerts the moment positions change.